Wojciech A. Cieslikowski

Poznan, WP 60355, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Preoperative Plasma Cell-Free DNA Integrity Index in Clear Cell Renal Cell Carcinoma: An Exploratory Case-Control Study.

Preoperative Plasma Cell-Free DNA Integrity Index in Clear Cell Renal Cell Carcinoma: An Exploratory Case-Control Study.

Journal: Cancers

Published: June 28, 2026

Contemporary Preoperative Detection of Extraprostatic Extension in Prostate Cancer.

Contemporary Preoperative Detection of Extraprostatic Extension in Prostate Cancer.

Journal: Cancers

Published: December 30, 2025

Recurrent Evisceration After Cystoprostatectomy in a Multimorbid Patient: A Case Report.

Recurrent Evisceration After Cystoprostatectomy in a Multimorbid Patient: A Case Report.

Journal: Cureus

Published: September 11, 2025

Beyond the Swelling: A Missed Foreign Body in the Testis.

Beyond the Swelling: A Missed Foreign Body in the Testis.

Journal: Cureus

Published: August 22, 2025

Learning curve for laparoscopic radical prostatectomy.

Learning curve for laparoscopic radical prostatectomy.

Journal: Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques

Published: October 22, 2024

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer.

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer.

Journal: Journal of personalized medicine

Published: March 10, 2023

Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis.

Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis.

Journal: International journal of environmental research and public health

Published: January 31, 2023

Preoperative cell-free DNA concentration in plasma as a diagnostic and prognostic biomarker of clear cell renal cell carcinoma.

Preoperative cell-free DNA concentration in plasma as a diagnostic and prognostic biomarker of clear cell renal cell carcinoma.

Journal: Contemporary oncology (Poznan, Poland)

Published: January 01, 2023

Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management.

Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management.

Journal: Biomedicines

Published: July 30, 2021

Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells.

Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells.

Journal: EXCLI journal

Published: June 12, 2021

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer.

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer.

Journal: Cancers

Published: December 17, 2019

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Journal: Cancers

Published: May 05, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026